微创颅内血肿清除术治疗高血压脑出血的效果体会  

Minimally Invasive Treatment of Intracranial Hematoma for Hypertensive Cerebral Hemorrhage

作　　者：王健 WANG Jian(Department of Neurosurgery,Zaozhuang Mining Group Hospital,Zaozhuang,Shandong Province,277100 China)

机构地区：[1]神经外科枣庄矿业集团枣庄医院,山东枣庄277100

出　　处：《中外医疗》2018年第14期94-95,98,共3页China & Foreign Medical Treatment

摘　　要：目的探索微创颅内血肿清除术应用在高血压脑出血治疗中的临床疗效。方法方便选取该院2015年8月—2016年12月期间所收治的66例高血压脑出血患者作为该次研究病例,按照手术方法的不同,将其分为研究组和参照组,每组33例,研究组应用YL-1型穿刺针刺入血肿边缘的微创手术治疗,参照组应用降压药与清除自由基等保守治疗,对比分析两组的临床效果,并观察神经功能恢复情况与手术后的生活能力以及血肿清除时间。结果研究组血肿清除时间为(4.51±1.19)d,参照组血肿清除时间为(16.80±1.92)d,(t=31.254 8,P=0.000 0);研究组预后良好29例(87.88%),预后不良4例,无死亡,参照组预后良好22例(66.67%),预后不良11例,无死亡(χ2=4.227 5,P=0.039 7);研究组总有效率为93.94%,显著高于参照组(75.76%),研究组不良反应发生率为9.09%,显著低于参照组(36.36%),组间差异有统计学意义。结论微创颅内血肿清除术应用在高血压脑出血治疗中的效果显著,能够有效提高患者的生存治疗,缩短患者的血肿清除时间,值得临床进一步应用探索。Objective This paper tries to explore the clinical efficacy of minimally invasive intracranial hematoma removal in the treatment of hypertensive intracerebral hemorrhage. Methods 66 patients with hypertensive intracerebral hemorrhage who were admitted conveniently to this hospital from August 2015 to December 2016 were selected as the study case. According to the different surgical methods, they were divided into study group and reference group, with 33 cases in each group. The study group applied a YL-1 puncture needle to the minimally invasive surgical treatment of the hematoma margin. The reference group was treated with antihypertensive drugs and free radical scavenging and other conservative treatments. The clinical effects of the two groups were compared and the neurological function recovery and postoperative living ability and hematoma removal time were observed. Results The hematoma clearance time in the study group was（4.51 ±1.19） days, and the hematoma clearance time in the reference group was（16.80±1.92） days.（t=31.254 8, P=0.000 0）; the study group had good prognosis in 29 cases（87.88%）. There were 4 patients with poor results and no deaths. The reference group had a good prognosis of 22 cases（66.67%）, 11 cases had a poor prognosis, and no death.（χ^2=4.227 5, P=0.039 7）; the total effective rate in the study group was 93.94%, significantly higher than the reference group（75.76%）, the incidence of adverse reactions in the study group was 9.09%, which was significantly lower than the reference group（36.36%）. The difference between the groups was statistically significant. Conclusion Minimally invasive intracranial hematoma removal is effective in the treatment of hypertensive intracerebral hemorrhage. It can effectively improve the survival and treatment of patients, shorten the hematoma eradication time, and is worthy of further clinical application.

关 键 词：微创颅内血肿清除术 高血压 脑出血 颅内血肿 

分 类 号：R4[医药卫生—临床医学]